Who is sponsoring NCT03285061?

NCT03285061 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT03285061?

Interventions in NCT03285061: Deterra Drug Deactivation System.

What condition does NCT03285061 study?

NCT03285061 studies Medication Disposal, Behavior.

Is NCT03285061 still recruiting?

NCT03285061 is currently completed. Last updated 6 January 2021.

Are results published for NCT03285061?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-01-06 · How we verify

NCT03285061

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery

Completed NA Results posted Last updated 6 January 2021

What this trial tests

NA trial testing Deterra Drug Deactivation System in Medication Disposal in 75 participants. Completed in 1 July 2019.

Timeline

1 October 2017

Primary endpoint
1 July 2019

1 July 2019

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	75
Start date	1 October 2017
Primary completion	1 July 2019
Estimated completion	1 July 2019
Sites	1 location across United States

Drugs / interventions tested

Deterra Drug Deactivation System

Conditions studied

Medication Disposal — all drugs for Medication Disposal →
Behavior — all drugs for Behavior →

Sponsor

Brigham and Women's Hospital

Who can join

18 and older, any sex, with Medication Disposal or Behavior. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Who Safely Disposed The Excess Medication Primary · 6 weeks

Patients will be given a survey to obtain their method of disposal for excess post-operative pain medication.

Group	Value	95% CI
Standard Disposal Instructions	8
At Home Disposal	22

Sponsor's own description

This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at medication drop off locations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Deterra Drug Deactivation System

Trials testing the same drug.

NCT03179566 — Pain and Medication Use Following Surgery · NA · completed

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03285061 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 6 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03285061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing